APA (7th ed.) Citation

T, Y., K, I., F, U., T, T., T, U., L, I., . . . T, K. (2026). Real-world safety and effectiveness of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: A multicenter Japanese cohort study. Urologic oncology. https://doi.org/10.1016/j.urolonc.2026.06.019

Chicago Style (17th ed.) Citation

T, Yanagisawa, et al. "Real-world Safety and Effectiveness of Enfortumab Vedotin Plus Pembrolizumab in Locally Advanced or Metastatic Urothelial Carcinoma: A Multicenter Japanese Cohort Study." Urologic Oncology 2026. https://doi.org/10.1016/j.urolonc.2026.06.019.

MLA (9th ed.) Citation

T, Yanagisawa, et al. "Real-world Safety and Effectiveness of Enfortumab Vedotin Plus Pembrolizumab in Locally Advanced or Metastatic Urothelial Carcinoma: A Multicenter Japanese Cohort Study." Urologic Oncology, 2026, https://doi.org/10.1016/j.urolonc.2026.06.019.